# Netskope Inc: overview

NTSK · Nasdaq · CIK 2063196 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/ntsk.md) · [Financials](/companies/ntsk/financials.md) · [Filings](/companies/ntsk/filings.md) · [Insiders](/companies/ntsk/insiders.md)

Latest reported revenue: [$220.5m](/filings/0001193125-26-380428.md) for Q2 FY2026, three months to 2026-07-31, from the 10-Q filed Sep 2, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-380428).

## Last eight quarters

| Line item | Unit | period not labelled (2024-10-31) | period not labelled (2025-01-31) | period not labelled (2025-04-30) | period not labelled (2025-07-31) | Q3 FY2025 (2025-10-31) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [139](/filings/0001193125-25-316190.md) | [148 d](/filings/0001193125-26-135011.md) | [158](/filings/0001193125-26-255732.md) | [171](/filings/0001193125-26-380428.md) | [184](/filings/0001193125-25-316190.md) | [196 d](/filings/0001193125-26-135011.md) | [202](/filings/0001193125-26-255732.md) | [221](/filings/0001193125-26-380428.md) |
| Gross margin | % | [66.2%](/filings/0001193125-25-316190.md) | [66.9% d](/filings/0001193125-26-135011.md) | [69.4%](/filings/0001193125-26-255732.md) | [72.2%](/filings/0001193125-26-380428.md) | [57.9%](/filings/0001193125-25-316190.md) | [73.0% d](/filings/0001193125-26-135011.md) | [73.5%](/filings/0001193125-26-255732.md) | [73.9%](/filings/0001193125-26-380428.md) |
| Operating margin | % | [(38.9%)](/filings/0001193125-25-316190.md) | [(27.7%) d](/filings/0001193125-26-135011.md) | [(28.8%)](/filings/0001193125-26-255732.md) | [(26.9%)](/filings/0001193125-26-380428.md) | [(242.7%)](/filings/0001193125-25-316190.md) | [(58.2%) d](/filings/0001193125-26-135011.md) | [(53.9%)](/filings/0001193125-26-255732.md) | [(40.7%)](/filings/0001193125-26-380428.md) |
| Net margin | % | [(51.1%)](/filings/0001193125-25-316190.md) | [(51.9%) d](/filings/0001193125-26-135011.md) | [(50.2%)](/filings/0001193125-26-380428.md) | [(52.9%)](/filings/0001193125-26-380428.md) | [(246.0%)](/filings/0001193125-25-316190.md) | [(28.9%) d](/filings/0001193125-26-135011.md) | [(57.8%)](/filings/0001193125-26-380428.md) | [(50.2%)](/filings/0001193125-26-380428.md) |
| Diluted EPS | $ per share | [(0.72)](/filings/0001193125-25-316190.md) | not reported | [(0.76)](/filings/0001193125-26-255732.md) | [(0.84)](/filings/0001193125-26-380428.md) | [(1.85)](/filings/0001193125-25-316190.md) | not reported | [(0.29)](/filings/0001193125-26-255732.md) | [(0.27)](/filings/0001193125-26-380428.md) |
| Free cash flow | $m | not reported | [4.9 d](/filings/0001193125-26-135011.md) | [18.2](/filings/0001193125-26-255732.md) | [(18.5) d](/filings/0001193125-26-380428.md) | [10.7 d](/filings/0001193125-25-316190.md) | [4.8 d](/filings/0001193125-26-135011.md) | [(56.1)](/filings/0001193125-26-255732.md) | [(29.5) d](/filings/0001193125-26-380428.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY (2024-01-31) | FY (2025-01-31) | FY2025 (2026-01-31) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $m | [407](/filings/0001193125-26-135011.md) | [538](/filings/0001193125-26-135011.md) | [709](/filings/0001193125-26-135011.md) |
| Gross margin | % | [59.8%](/filings/0001193125-26-135011.md) | [64.6%](/filings/0001193125-26-135011.md) | [68.1%](/filings/0001193125-26-135011.md) |
| Operating margin | % | [(76.9%)](/filings/0001193125-26-135011.md) | [(47.5%)](/filings/0001193125-26-135011.md) | [(92.0%)](/filings/0001193125-26-135011.md) |
| Net margin | % | [(84.8%)](/filings/0001193125-26-135011.md) | [(65.9%)](/filings/0001193125-26-135011.md) | [(95.8%)](/filings/0001193125-26-135011.md) |
| Diluted EPS | $ per share | [(3.77)](/filings/0001193125-26-135011.md) | [(3.64)](/filings/0001193125-26-135011.md) | [(3.18)](/filings/0001193125-26-135011.md) |
| Free cash flow | $m | [(198)](/filings/0001193125-26-135011.md) | [(144)](/filings/0001193125-26-135011.md) | [15.2](/filings/0001193125-26-135011.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ntsk/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [ICONIQ Capital, LLC](/funds/1569709.md) | 2026-06-30 | $725.0m | 66,267,513 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $101.8m | 9,301,737 |  | Added +5,898,088 |
| [CANADA PENSION PLAN INVESTMENT BOARD](/funds/1283718.md) | 2026-06-30 | $98.0m | 8,960,263 |  | New +8,960,263 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $83.6m | 7,644,168 |  | Added +5,136,089 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $80.1m | 7,319,472 |  | Added +4,461,185 |
| [SAPPHIRE VENTURES, L.P.](/funds/1697665.md) | 2026-06-30 | $55.1m | 5,038,679 |  | Reduced −633,900 |
| [BAMCO INC /NY/](/funds/1017918.md) | 2026-06-30 | $50.0m | 4,567,336 |  | Added +743,258 |
| [FIRST TRUST ADVISORS LP](/funds/1125816.md) | 2026-06-30 | $46.3m | 4,235,756 |  | Added +4,225,414 |
| [MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.](/funds/1705339.md) | 2026-06-30 | $45.1m | 4,122,436 |  | Added +2,956,301 |
| [CITIGROUP INC](/funds/831001.md) | 2026-06-30 | $43.0m | 3,930,520 |  | Added +3,894,784 |

## Recent filings

[All 136 filings](/companies/ntsk/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-02 | 21:05 ET | [10-Q](/filings/0001193125-26-380428.md) | Quarterly report, period 2026-07-31 | 0001193125-26-380428 |
| 2026-09-02 | 20:10 ET | [8-K](/filings/0001193125-26-380188.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-380188 |
| 2026-07-10 | 22:55 ET | [8-K](/filings/0001193125-26-299930.md) | 5.07 Shareholder vote results | 0001193125-26-299930 |
| 2026-06-03 | 21:05 ET | [10-Q](/filings/0001193125-26-255732.md) | Quarterly report, period 2026-04-30 | 0001193125-26-255732 |
| 2026-06-03 | 20:10 ET | [8-K](/filings/0001193125-26-255439.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-255439 |
| 2026-05-27 | 21:01 ET | [DEF 14A](/filings/0001193125-26-242108.md) | Proxy statement, period 2026-07-07 | 0001193125-26-242108 |
| 2026-03-31 | 21:29 ET | [10-K](/filings/0001193125-26-135011.md) | Annual report, period 2026-01-31 | 0001193125-26-135011 |
| 2026-03-11 | 20:10 ET | [8-K](/filings/0001193125-26-102142.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-102142 |
| 2025-12-11 | 22:11 ET | [10-Q](/filings/0001193125-25-316190.md) | Quarterly report, period 2025-10-31 | 0001193125-25-316190 |
| 2025-12-11 | 21:15 ET | [8-K](/filings/0001193125-25-315967.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-315967 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 31, 2026](/filings/0001193125-26-135011.md), filed Mar 31, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 2063196
- Tickers: NTSK
- Exchange: Nasdaq
- SIC code: 7372 Services-Prepackaged Software
- State of incorporation: DE
- Filer category: Non-accelerated filer<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.
